Resultados de la atención perinatal en el año 2007. Evolución en el último decenio / Results of perinatal care in 2007. Evolution in the last decade

Para conocer la calidad de la atención sanitaria que ofrecemos a las gestantes, es imprescindible conocer nuestros resultados y compararlos. Con esta finalidad, presentamos los resultados de la asistencia al parto durante el año 2007. Destacamos: mantenemos una tasa baja de cesáreas (13,65%) y de partos instrumentales (5,18%), aunque se ha puesto en marcha un programa de atención al parto con analgesia epidural (el 35% se atienden con esta técnica). Las tasas de mortalidad perinatal estándar y ampliada han disminuido un 70%, en 10 años. Probablemente, en estos resultados influya que nuestro centro sigue las recomendaciones de la Organización Mundial de la Salud en relación con los cuidados que se deben realizar durante el parto. Nuestra filosofía es: «Interferir con el proceso fisiológico del parto en ausencia de indicación médica incrementa el riesgo de complicaciones para la madre y el recién nacido»(AU)

The determination and comparison of outcomes is essential to evaluate the quality of care provided to pregnant women. To do this, we present the results of perinatal care in 2007. The following results are emphasized: a low rate of cesarean sections (13.65%) and instrumental deliveries (5.18%) was maintained, although a program of delivery with epidural analgesia (35% of fetuses were delivered with this procedure) was started. The standard and expanded rate of perinatal mortality fell by 70% in 10 years. These results were probably influenced by our center’s policy of following the recommendations of the World Health Organization on the care provided during delivery. Our philosophy is that «to Interfere with the physiological process of childbirth without medical indication increases the risk of complications for the mother and newborn»(AU)

Flow injection chemiluminescent determination of amiodarone in pharmaceutical preparations using photogenerated tris(2,2'-bipyridyl)ruthenium(III).

A flow injection configuration was developed and evaluated for the chemiluminescent determination of amiodarone. The method is based on the reaction of the drug with tris(2,2'-bipyridyl)ruthenium(III), which was generated through the on-line photo-oxidation of tris(2,2'-bipyridyl)ruthenium(II) with peroxydisulfate. Under the optimum experimental conditions, a linear calibration graph was obtained over the range 3.0-60.0 microg ml(-1) with a detection limit of 0.28 microg ml(-1). The proposed method allows 120 injections h(-1) with excellent repeatability and precision (R.S.D. less than 0.5% and 2.8%, respectively) and a reagent consumption of only 0.37 micromol (0.27 mg) of Ru(bpy)(3)Cl(2) x 6H(2)O per determination. The method was successfully applied to the determination of amiodarone in commercial pharmaceutical formulations.